Results

Total Results: 9,447 records

Showing results for "cancer".
Users also searched for: colon cancer screening

361. Disposition of Comments Report for Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-pancreas_disposition-comments.pdf
     September 23, 2014 - in early stage small tumors. … Response Peer Reviewer 4 General Comments About Key Question 2 Most of data for staging of pancreatic cancers … However studies reporting outcomes in pancreatic cancer patients report that tumor size and locoregional … EUS is valuable in determining resectability of small tumors or tumors that are not visualized on CT … but EUS has clear advantage for small tumor and for pancreatic neuoendocrine tumors (Gastrointest

362. Technical Brief Protocol_ 0369 Models of Survivorship Care_2-15-13_v14[1] (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-survivor-care-transition_research-protocol.pdf
     March 27, 2013 - Search "Survivors"[Mesh] OR survivorship OR survivor Filters: Humans; English 498,795 #10 Search "Neoplasms … Search 23257892[uid] 1 #2 Search "Survivors"[Mesh] OR survivorship OR survivor 771137 #3 Search "Neoplasms … #12 Search (#1 AND #9) 0 #13 Search (#1 AND #9) Schema: all 0 Search (("Survivors"[MAJR] AND "Neoplasms … late effects of treatment, second cancers, and poor quality of life, to provide a knowledge base regarding … optimal followup care and surveillance of cancers, and to optimize health after cancer treatment.

363. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests_executive.pdf
     February 01, 2006 - Layout 1 Background Breast cancer is the second most common malignancy in women. … If a noninvasive diagnostic test were available that could accurately exclude malignancy, many women … , each would miss some cancers. … PET scan, about 924 women would have avoided an unnecessary biopsy, but 76 women would have missed cancers … negative US, about 950 women would have avoided an unnecessary biopsy, but 50 women would have missed cancers

364. Screening for Colorectal Cancer: Clinical Summary of USPSTF Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/DcUgaNRhU6PvJWXqqsa8X7
     Screening for Colorectal Cancer: Clinical Summary of USPSTF Recommendation Figure. … Screening for Colorectal Cancer: Clinical Summary Population Adults aged 50 to 75 y Adults aged 76 … to 85 y Recommendation Screen for colorectal cancer starting at age 50 y. … Grade: A The decision to screen for colorectal cancer is an individual one. … excision or simple polypectomy for tumors limited to the colonic mucosa or surgical resection (via

365. Prostate-Cancer-Therapies-Update Consumer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_consumer.pdf
     January 01, 2016 - Prostate cancer is the most common cancer in men other than skin cancer. … cancer? … Your doctor can use your PSA level, Gleason score, and tumor score (T-score) to determine your risk … Tumor Score (T-score) The T-score tells how far your prostate cancer has grown. … cancer.

366. Nis 2004 Summarystats 10Pct Sample A (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_10PCT_SAMPLE_A.PDF
     January 01, 2004 - cancer of skin 118 0.01 24: Cancer of breast 1925 0.24 25: Cancer of uterus 782 0.10 26: Cancer of … : Cancer of prostate 1673 0.21 30: Cancer of testis 41 0.01 31: Cancer of other male genital organs … , other Unspecified primary 175 0.02 42: Secondary malignancies 5032 0.63 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3383 0.42 46: Benign neoplasm of uterus 4826 0.60 47: Other … unspecified benign neoplasm 3769 0.47 48: Thyroid disorders 881 0.11 49: Diabetes mellitus without

367. Nis 2003 Summarystats 10Pct Sample B (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2003_SummaryStats_10PCT_SAMPLE_B.PDF
     January 01, 2003 - cancer of skin 136 0.02 24: Cancer of breast 2043 0.26 25: Cancer of uterus 708 0.09 26: Cancer of … : Cancer of prostate 1877 0.24 30: Cancer of testis 41 0.01 31: Cancer of other male genital organs … , other Unspecified primary 176 0.02 42: Secondary malignancies 5165 0.65 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3173 0.40 46: Benign neoplasm of uterus 5158 0.65 47: Other … unspecified benign neoplasm 3660 0.46 48: Thyroid disorders 1034 0.13 49: Diabetes mellitus without

368. Nis 2004 Summarystats 10Pct Sample B (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_10PCT_SAMPLE_B.PDF
     January 01, 2004 - cancer of skin 139 0.02 24: Cancer of breast 1907 0.24 25: Cancer of uterus 754 0.09 26: Cancer of … : Cancer of prostate 1647 0.21 30: Cancer of testis 29 0.00 31: Cancer of other male genital organs … , other Unspecified primary 165 0.02 42: Secondary malignancies 5037 0.63 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3428 0.43 46: Benign neoplasm of uterus 4862 0.61 47: Other … unspecified benign neoplasm 3727 0.47 48: Thyroid disorders 951 0.12 49: Diabetes mellitus without

369. Nis 2003 Summarystats 10Pct Sample A (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2003_SummaryStats_10PCT_SAMPLE_A.PDF
     January 01, 2003 - cancer of skin 158 0.02 24: Cancer of breast 1910 0.24 25: Cancer of uterus 731 0.09 26: Cancer of … : Cancer of prostate 1912 0.24 30: Cancer of testis 33 0.00 31: Cancer of other male genital organs … , other Unspecified primary 179 0.02 42: Secondary malignancies 5247 0.66 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3120 0.39 46: Benign neoplasm of uterus 5073 0.64 47: Other … unspecified benign neoplasm 3710 0.47 48: Thyroid disorders 935 0.12 49: Diabetes mellitus without

370. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/60825/psn-pdf
     August 19, 2020 - Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer … Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival … backlog in cancer referrals on cancer survival. … proportion of patients with early-stage tumors progressing from having curable to incurable disease … https://psnet.ahrq.gov/issue/effect-delays-2-week-wait-cancer-referral-pathway-during-covid-19-pandemic-cancer-survival-uk

371. Publicsummarystats Kid 2006 Core (pdf file)
     hcup-us.ahrq.gov/db/nation/kid/tools/stats/PublicSummaryStats_KID_2006_Core.PDF
     January 01, 2006 - 322 0.01 17: Cancer of pancreas 21 0.00 18: Cancer of other GI organs, peritoneum 255 0.01 19: Cancer … of skin 43 0.00 24: Cancer of breast 12 0.00 25: Cancer of uterus <= 10 **.** 26: Cancer of cervix … 23 0.00 27: Cancer of ovary 200 0.01 28: Cancer of other female genital organs 17 0.00 29: Cancer … 1196 0.04 42: Secondary malignancies 1260 0.04 43: Malignant neoplasm without specification of site … , radiotherapy 24803 0.79 46: Benign neoplasm of uterus 54 0.00 47: Other unspecified benign neoplasm

372. Kid 2000 Summarystats Core (pdf file)
     hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2000_SummaryStats_CORE.PDF
     January 01, 2000 - cancer of skin 34 0.00 24: Cancer of breast <= 10 **.** 25: Cancer of uterus 11 0.00 26: Cancer of … Cancer of prostate 19 0.00 30: Cancer of testis 139 0.01 31: Cancer of other male genital organs < … , other Unspecified primary 1133 0.05 42: Secondary malignancies 960 0.04 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 19716 0.78 46: Benign neoplasm of uterus 48 0.00 47: Other … unspecified benign neoplasm 5345 0.21 48: Thyroid disorders 566 0.02 49: Diabetes mellitus without

373. Nis 2005 Summarystats Core (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2005_SummaryStats_CORE.PDF
     January 01, 2005 - cancer of skin 1287 0.02 24: Cancer of breast 18543 0.23 25: Cancer of uterus 8800 0.11 26: Cancer … 29: Cancer of prostate 16748 0.21 30: Cancer of testis 363 0.00 31: Cancer of other male genital … , other Unspecified primary 1911 0.02 42: Secondary malignancies 51530 0.64 43: Malignant neoplasm … 0.13 45: Maintenance chemotherapy, radiotherapy 35067 0.44 46: Benign neoplasm of uterus 46171 0.58 … 47: Other unspecified benign neoplasm 35613 0.45 48: Thyroid disorders 9484 0.12 49: Diabetes mellitus

374. Nis 2003 Summarystats Core (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2003_SummaryStats_CORE.PDF
     January 01, 2003 - cancer of skin 1350 0.02 24: Cancer of breast 19946 0.25 25: Cancer of uterus 7324 0.09 26: Cancer … 29: Cancer of prostate 18802 0.24 30: Cancer of testis 368 0.00 31: Cancer of other male genital … , other Unspecified primary 1727 0.02 42: Secondary malignancies 52369 0.66 43: Malignant neoplasm … 0.13 45: Maintenance chemotherapy, radiotherapy 31272 0.39 46: Benign neoplasm of uterus 50654 0.63 … 47: Other unspecified benign neoplasm 36711 0.46 48: Thyroid disorders 9417 0.12 49: Diabetes mellitus

375. Microsoft Word - AF_Report2006_fin.doc (pdf file)
     hcup-us.ahrq.gov/reports/methods/2008_04.pdf
     January 01, 2008 - ; other and unspecified primary 1.00 1.00 0.97 1.04 1.02 0.99 0.95 42: Secondary malignancies 1.04 1.02 … Malignant neoplasm without specification of site 1.05 1.03 1.08 1.06 1.08 0.96 1.04 44. … Neoplasms of unspecified nature or uncertain behavior 0.98 0.97 0.96 1.00 0.96 1.03 0.96 45: Maintenance … chemotherapy; radiotherapy 0.95 0.92 0.94 0.99 0.92 1.01 0.97 46: Benign neoplasm of uterus 0.87 0.86 … 0.80 0.95 0.84 1.00 0.85 47: Other and unspecified benign neoplasm 0.93 0.92 0.88 0.98 0.92 1.00 0.91

376. CER 174 Executive Summary: Imaging for the Pretreatment of Small Cell Lung Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/lung-cancer-staging_executive.pdf
     April 01, 2016 - percent of all lung cancers.3 Despite advances in diagnosis, treatment, and management of lung … Lung cancers are classified based on the size of the main tumor, whether it has locally invaded other … anatomic sites that harbor metabolically active malignant areas, FDG-PET helps distinguish malignant tumors … patient/tumor factor. … the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node

377. Final Progress Report: Oral Chemotherapy Safety in Ambulatory Oncology: A Proactive Risk Assessment (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/weingart-report.pdf
     January 01, 2024 - melanoma), capecitabine (advanced GI and breast), imatinib (chronic myelogenous leukemia and GI stromal tumors … melanoma), capecitabine (advanced Gl and breast), imatinib (chronic myelogenous leukemia and Gl stromal tumors … ), and a phase II investigational agent named XL820 (advanced gastrointestinal stromal tumors). … Participants had various types of cancers and used a variety of oral chemotherapies. … For example, the cognitive impairments common among brain tumor patients made it important to engage

378. Comparative Effectiveness Research Review Disposition of Comments Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests-update_disposition-comments.pdf
     February 13, 2012 - In addition, the prior probability of malignancy based on the patients risk of breast cancer is rarely … Anderson Cancer Center13 that compared length of survival of metastatic breast cancer patients treated … There is a considerable body of literature discussing lobular cancers and difficulties in detecting … biopsies revealed 34% malignancies, of which 78.4% were invasive cancers and 21.6% were ductal carcinoma … as distinguished from CADe (computer-aided detection), and CADq (computer-aided quantification of tumor

379. Kid 2003 Summarystats Core (pdf file)
     hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2003_SummaryStats_CORE.PDF
     January 01, 2003 - of head and neck 182 0.01 13: Cancer of stomach 13 0.00 14: Cancer of colon 55 0.00 15: Cancer of … 0.01 28: Cancer of other female genital organs 32 0.00 29: Cancer of prostate 27 0.00 30: Cancer … primary 1184 0.04 42: Secondary malignancies 1144 0.04 43: Malignant neoplasm without specification … chemotherapy, radiotherapy 23766 0.80 46: Benign neoplasm of uterus 56 0.00 47: Other unspecified … benign neoplasm 6057 0.20 48: Thyroid disorders 742 0.02 49: Diabetes mellitus without complication

380. eCoach: Development and Pilot Testing of a Decision Aid for Prostate Cancer - 2012 | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/ecoach-development-and-pilot-testing-decision-aid-prostate-cancer/annual-summary/2012
     January 01, 2012 - eCoach: Development and Pilot Testing of a Decision Aid for Prostate Cancer - 2012 Project … Prostate cancer is an ideal condition to investigate the use of ECAs because it is the most common cancer … diagnosed among men in the United States, and ranks second for tumor site-specific mortality. … use of prostate-specific antibody (PSA) as a screening test has led to earlier diagnosis of prostate cancers … patients about the risks and benefits of treating their cancer.